Advanced search
Publication Cover
International Journal of Nanomedicine Volume 14, 2019 - Issue
Submit an article Journal homepage
68
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo

Xiao-Chuan Duan1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Xin Yao1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Shuang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Mei-Qi Xu1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Yan-Li Hao1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Zhan-Tao Li1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Xiu-Chai Zheng2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Man Liu1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Zhuo-Yue Li1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Hui Li1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Jing-Ru Wang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
,
Zhen-Han Feng1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]
&
Xuan Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected];2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, People’s Republic of China, [email protected]Correspondence[email protected]
 show all
Pages 195-204 | Published online: 24 Dec 2018

References

  • WilsonWRHayMPTargeting hypoxia in cancer therapyNat Rev Cancer201111639341021606941
  • PhillipsRMTargeting the hypoxic fraction of tumours using hypoxia-activated prodrugsCancer Chemother Pharmacol201677344145726811177
  • GuiseCPMowdayAMAshoorzadehABioreductive prodrugs as cancer therapeutics: targeting tumor hypoxiaChin J Cancer2014332808623845143
  • MukerabigwiJFGeZKataokaKTherapeutic Nanoreactors as In Vivo Nanoplatforms for Cancer TherapyChemistry20182459157061572429572992
  • SunTZhangYSPangBHyunDCYangMXiaYEngineered nanoparticles for drug delivery in cancer therapyAngew Chem Int Ed201453461232012364
  • ChenSZaifmanJKulkarniJADexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acidsJ Control Release2018286465430026080
  • WangGWangZLiCRGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapyBiomed Pharmacother201810627528429966971
  • LingXChenXRiddellIAGlutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin ResistanceNano Lett20181874618462529902013
  • SignorellRDLucianiPBrambillaDLerouxJCPharmacokinetics of lipid-drug conjugates loaded into liposomesEur J Pharm Biopharm201812818819929678733
  • GuoDXuSWangNProdrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapyBiomaterials201714418819828837960
  • CheethamAGChakrounRWMaWCuiHSelf-assembling prodrugsChem Soc Rev201746216638666329019492
  • ZhongTYaoXZhangSA self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristicSci Rep201663661427812039
  • ZhongTHaoYLYaoXEffect of XlogP and Hansen Solubility Parameters on Small Molecule Modified Paclitaxel Anticancer Drug Conjugates Self-Assembled into NanoparticlesBioconjug Chem201829243744429300459
  • SongPYaoXZhongTThe anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrugOncotarget2016730484674848027366947
  • ZhengXCRenWZhangSThe theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticlesInt J Nanomedicine2018131495150429559778
  • duRZhongTZhangWQAntitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanomaInt J Nanomedicine201493091310525028548
  • GuoYZhongTDuanXCImproving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrixDrug Deliv201724127027728165798
  • LuoLMHuangYZhaoBXAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials20133441102111423127332
  • ZhaoBXZhaoYHuangYThe efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxelBiomaterials20123382508252022197569
  • RautioJMeanwellNAdiLHagemanMJThe expanding role of prodrugs in contemporary drug design and developmentNat Rev Drug Discov201817855958729700501
  • RautioJKärkkäinenJSloanKBProdrugs – Recent approvals and a glimpse of the pipelineEur J Pharm Sci201710914616128782609
  • KrzywinskaEStockmannChypoxia, metabolism and immune cell functionBiomedicines20186256
  • ChistiakovDAMyasoedovaVAOrekhovANBobryshevYVnanocarriers in improving chemotherapy of multidrug resistant tumors: key developments and perspectivesCurr Pharm Des201723223301330828403792
  • YameenBChoiWIVilosCSwamiAShiJFarokhzadOCInsight into nanoparticle cellular uptake and intracellular targetingJ Control Release201419048549924984011
  • BehzadiSSerpooshanVTaoWCellular uptake of nanoparticles: journey inside the cellChem Soc Rev201746144218424428585944
  • SalatinSMaleki DizajSYari KhosroushahiAEffect of the surface modification, size, and shape on cellular uptake of nanoparticlesCell Biol Int201539888189025790433
  • RabinovitchMProfessional and non-professional phagocytes: an introductionTrends Cell Biol199553858714732160
  • FalconeSCocucciEPodiniPKirchhausenTClementiEMeldolesiJMacropinocytosis: regulated coordination of endocytic and exocytic membrane traffic eventsJ Cell Sci2006119Pt 224758476917077125
  • PartonRGSimonsKThe multiple faces of caveolaeNat Rev Mol Cell Biol20078318519417318224
  • RejmanJOberleVZuhornISHoekstraDSize-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosisBiochem J2004377Pt 115916914505488

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.